Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-11-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.14641 |
| _version_ | 1797989251293380608 |
|---|---|
| author | Jun Wang Zhouguang Hui Qingsong Pang |
| author_facet | Jun Wang Zhouguang Hui Qingsong Pang |
| author_sort | Jun Wang |
| collection | DOAJ |
| first_indexed | 2024-04-11T08:16:03Z |
| format | Article |
| id | doaj.art-893b98c9b7514311bf9019e611d1d3fd |
| institution | Directory Open Access Journal |
| issn | 1759-7706 1759-7714 |
| language | English |
| last_indexed | 2024-04-11T08:16:03Z |
| publishDate | 2022-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Thoracic Cancer |
| spelling | doaj.art-893b98c9b7514311bf9019e611d1d3fd2022-12-22T04:35:09ZengWileyThoracic Cancer1759-77061759-77142022-11-0113213099310010.1111/1759-7714.14641Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?Jun Wang0Zhouguang Hui1Qingsong Pang2Department of Radiation Oncology the Fourth Hospital of Hebei Medical University, Hebei Clinical Research Center for Radiation Oncology Shijiazhuang ChinaDepartment of VIP Medical Services and Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Radiation Oncology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin Chinahttps://doi.org/10.1111/1759-7714.14641adjuvant therapyconcurrent chemoradiotherapyesophageal squamous cell carcinomaimmunotherapy |
| spellingShingle | Jun Wang Zhouguang Hui Qingsong Pang Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? Thoracic Cancer adjuvant therapy concurrent chemoradiotherapy esophageal squamous cell carcinoma immunotherapy |
| title | Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? |
| title_full | Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? |
| title_fullStr | Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? |
| title_full_unstemmed | Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? |
| title_short | Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma? |
| title_sort | is adjuvant immunotherapy a new standard for non pathological complete response patients with resectable esophageal squamous cell carcinoma |
| topic | adjuvant therapy concurrent chemoradiotherapy esophageal squamous cell carcinoma immunotherapy |
| url | https://doi.org/10.1111/1759-7714.14641 |
| work_keys_str_mv | AT junwang isadjuvantimmunotherapyanewstandardfornonpathologicalcompleteresponsepatientswithresectableesophagealsquamouscellcarcinoma AT zhouguanghui isadjuvantimmunotherapyanewstandardfornonpathologicalcompleteresponsepatientswithresectableesophagealsquamouscellcarcinoma AT qingsongpang isadjuvantimmunotherapyanewstandardfornonpathologicalcompleteresponsepatientswithresectableesophagealsquamouscellcarcinoma |